TNXP - Tonix Pharmaceuticals Holding Corp.

13.45
-0.270   -2.007%

Share volume: 277,507
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$13.72
-0.27
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
21%
Profitability 25%
Dept financing 4%
Liquidity 50%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.79%
1 Month
-17.23%
3 Months
-32.38%
6 Months
-46.82%
1 Year
3.30%
2 Year
12.65%
Key data
Stock price
$13.45
P/E Ratio 
0.00
DAY RANGE
$13.07 - $13.72
EPS 
-$40.31
52 WEEK RANGE
$12.35 - $69.97
52 WEEK CHANGE
-$0.15
MARKET CAP 
211.784 M
YIELD 
N/A
SHARES OUTSTANDING 
11.777 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
02-05-2025
NEXT EARNINGS DATE
05-12-2025
BETA 
0.20
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$329,142
AVERAGE 30 VOLUME 
$326,391
Company detail
CEO: Seth Lederman
Region: US
Website: tonixpharma.com
Employees: 50
IPO year: 2012
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Tonix Pharmaceuticals Holding Corp. focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company was founded in 2007 and is headquartered in Chatham, New Jersey.

Recent news